Filamon

Tryptamine Therapeutics, located in Camberwell, Victoria, is a clinical-stage biotechnology company dedicated to pioneering innovative solutions in psychedelic drug development aimed at enhancing patient care. The company focuses on addressing neuropsychiatric disorders through therapeutic dosing of synthetic psilocybin and IV-infused psilocin, which seeks to overcome the limitations associated with orally administered treatments. Driven by a commitment to patient outcomes, Tryptamine Therapeutics is developing proprietary formulations and advanced dosing methods to improve the psychedelic experience for patients suffering from chronic pain and other conditions. With a strong management team and ongoing global patent pursuits, the company is on a mission to transform the treatment landscape for diseases with unmet medical needs. Generated from the website

Control Bionics Australia, located in Camberwell, Victoria, specializes in advanced assistive technology aimed at empowering individuals with communication and mobility challenges. Their innovative product range, including the NeuroNode systems and EyeGaze technology, is designed to enhance user independence and performance in both rehabilitation and athletic environments. The company focuses on providing solutions for people living with conditions such as paralysis, speech loss, and other movement limitations, helping them regain control over their lives. In addition to its assistive technology, Control Bionics also develops tools for sports performance and physical rehabilitation, pushing the boundaries of human potential and recovery. Generated from the website